https://www.selleckchem.com/pr....oducts/Everolimus(RA
In this study, we reported a new ex vivo therapeutic strategy combining macroencapsulation and cellular spheroids with scaffolds. This pack, macroencapsulated spheroids with scaffolds, can also be applied to other types of lysosomal diseases by modifying genes of interest. To investigate the prevalence of dry eye symptoms after successful dacryocystorhinostomy and explore the potential risk factors. This cross-sectional study included 565 patients with lacrimal passage obstruction (LPO) who underwent external dacryocystorhino